Emtricitabine Impurity 33 - Request Quote
Emtricitabine Impurity 33
| SZ CAT No: | SZ-E010076 |
| CAS No | NA |
| Mol.F. | C8H10FN3O3S |
| Mol.Wt. | 247.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Emtricitabine Impurity 33 is chemically 4-Amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one compound with 4-amino-5-fluoro-1-((2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one (1:1). Emtricitabine Impurity 33 is supplied with detailed characterization data compliant with regulatory guideline. Emtricitabine Impurity 33 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Emtricitabine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Emtricitabine Impurity 33
Purchase Emtricitabine Impurity 33
Emtricitabine Impurity 33 suppliers
Emtricitabine Impurity 33 manufacturers
Emtricitabine Impurity 33 price
Order Emtricitabine Impurity 33
Enquire Emtricitabine Impurity 33
Emtricitabine Impurity 33 cost
Emtricitabine Impurity 33 Supplier
Emtricitabine Impurity 33 Distributor
Emtricitabine Impurity 33 for Method Validation
Emtricitabine Reference Standard
Emtricitabine Impurity 33 for ANDA Filing
Emtricitabine Impurity 33 for Forced Degradation Studies
Emtricitabine Impurity 33 Identification Standards
Emtricitabine Impurity 33 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.